These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 2295065)
21. Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression. Hsu S; Huang F; Hafez M; Winawer S; Friedman E Cell Growth Differ; 1994 Mar; 5(3):267-75. PubMed ID: 8018559 [TBL] [Abstract][Full Text] [Related]
22. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer. Brunschwig EB; Wilson K; Mack D; Dawson D; Lawrence E; Willson JK; Lu S; Nosrati A; Rerko RM; Swinler S; Beard L; Lutterbaugh JD; Willis J; Platzer P; Markowitz S Cancer Res; 2003 Apr; 63(7):1568-75. PubMed ID: 12670906 [TBL] [Abstract][Full Text] [Related]
23. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate. Ohannesian DW; Lotan D; Lotan R Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433 [TBL] [Abstract][Full Text] [Related]
24. The role of nm23 in transforming growth factor beta 1-mediated adherence and growth arrest. Hsu S; Huang F; Wang L; Banerjee S; Winawer S; Friedman E Cell Growth Differ; 1994 Sep; 5(9):909-17. PubMed ID: 7819128 [TBL] [Abstract][Full Text] [Related]
25. Differential control of expression of type I and type II receptors of transforming growth factor-beta in colon carcinoma cells. Periyasamy S; Sun L; Gentry LE; Brattain MG J Cell Physiol; 1996 Sep; 168(3):711-20. PubMed ID: 8816926 [TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-beta 1 induces transforming growth factor-alpha promoter activity and transforming growth factor-alpha secretion in the human colon adenocarcinoma cell line FET. Lynch MJ; Pelosi L; Carboni JM; Merwin J; Coleman K; Wang RC; Lin PF; Henry DL; Brattain MG Cancer Res; 1993 Sep; 53(17):4041-7. PubMed ID: 8358733 [TBL] [Abstract][Full Text] [Related]
27. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide. Waxman S; Scher BM; Hellinger N; Scher W Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439 [TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model. Coffey RJ; Goustin AS; Soderquist AM; Shipley GD; Wolfshohl J; Carpenter G; Moses HL Cancer Res; 1987 Sep; 47(17):4590-4. PubMed ID: 2887281 [TBL] [Abstract][Full Text] [Related]
29. Involvement of transforming growth factor beta1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells. Shimizu S; Nishikawa Y; Kuroda K; Takagi S; Kozaki K; Hyuga S; Saga S; Matsuyama M Cancer Res; 1996 Jul; 56(14):3366-70. PubMed ID: 8764135 [TBL] [Abstract][Full Text] [Related]
30. Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line. Mulder KM; Ramey MK; Hoosein NM; Levine AE; Hinshaw XH; Brattain DE; Brattain MG Cancer Res; 1988 Dec; 48(24 Pt 1):7120-5. PubMed ID: 3191488 [TBL] [Abstract][Full Text] [Related]
31. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Barnard JA; Warwick G Cell Growth Differ; 1993 Jun; 4(6):495-501. PubMed ID: 8373733 [TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor beta isoform-specific differences in interactions with type I and II transforming growth factor beta receptors. Zhou GH; Sechrist GL; Periyasamy S; Brattain MG; Mulder KM Cancer Res; 1995 May; 55(10):2056-62. PubMed ID: 7743502 [TBL] [Abstract][Full Text] [Related]
33. [Differentiation effect of hexamethylene bisacetamide (HMBA) on mucoepidermoid carcinoma in vivo]. Jia B; Situ Z; Wu J Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Mar; 31(2):85-7. PubMed ID: 9387538 [TBL] [Abstract][Full Text] [Related]
34. Production of transforming growth factors by human colon cancer lines. Coffey RJ; Shipley GD; Moses HL Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610 [TBL] [Abstract][Full Text] [Related]
35. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells. Richon VM; Russo P; Venta-Perez G; Cordon-Cardo C; Rifkind RA; Marks PA Cancer Res; 1997 Jul; 57(13):2789-98. PubMed ID: 9205091 [TBL] [Abstract][Full Text] [Related]
36. Colon absorptive epithelial cells lose proliferative response to TGF alpha as they differentiate. Huang F; Sauma S; Yan Z; Friedman E Exp Cell Res; 1995 Jul; 219(1):8-14. PubMed ID: 7628553 [TBL] [Abstract][Full Text] [Related]
37. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120 [TBL] [Abstract][Full Text] [Related]
38. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation. Marks PA; Ramsay R; Sheffery M; Rifkind RA Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077 [TBL] [Abstract][Full Text] [Related]
39. Regulation of transforming growth factor alpha messenger RNA expression in a chemically transformed rat hepatic epithelial cell line by phorbol ester and hormones. Raymond VW; Lee DC; Grisham JW; Earp HS Cancer Res; 1989 Jul; 49(13):3608-12. PubMed ID: 2786455 [TBL] [Abstract][Full Text] [Related]
40. Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol. Arrick BA; Korc M; Derynck R Cancer Res; 1990 Jan; 50(2):299-303. PubMed ID: 2295070 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]